PMID- 22993404 OWN - NLM STAT- MEDLINE DCOM- 20130305 LR - 20211021 IS - 1538-7445 (Electronic) IS - 0008-5472 (Print) IS - 0008-5472 (Linking) VI - 72 IP - 22 DP - 2012 Nov 15 TI - Rat Mcs1b is concordant to the genome-wide association-identified breast cancer risk locus at human 5q11.2 and MIER3 is a candidate cancer susceptibility gene. PG - 6002-12 LID - 10.1158/0008-5472.CAN-12-0748 [doi] AB - Low-penetrance alleles associated with breast cancer risk have been identified in population-based studies. Most risk loci contain either no or multiple potential candidate genes. Rat mammary carcinoma susceptibility 1b (Mcs1b) is a quantitative trait locus on RN02 that confers decreased susceptibility when Copenhagen (COP)-resistant alleles are introgressed into a Wistar Furth (WF)-susceptible genome. Five WF.COP congenic lines containing COP RN02 segments were compared. One line developed an average of 3.4 +/- 2.0 and 5.5 +/- 3.6 mammary carcinomas per rat +/- SD when females were Mcs1b-resistant homozygous and Mcs1b heterozygous, respectively. These phenotypes were significantly different from susceptible genotype littermates (7.8 +/- 3.1 mean mammary carcinomas per rat +/- SD, P = 0.0001 and P = 0.0413, respectively). All other congenic lines tested were susceptible. Thus, Mcs1b was narrowed to 1.8 Mb of RN02 between genetic markers ENSRNOSNP2740854 and g2UL2-27. Mammary gland-graft carcinoma susceptibility assays were used to determine that donor (P = 0.0019), but not recipient Mcs1b genotype (P = 0.9381), was associated with ectopic mammary carcinoma outcome. Rat Mcs1b contains sequence orthologous to human 5q11.2, a breast cancer susceptibility locus identified in multiple genome-wide association studies. Human/rat MAP3K1/Map3k1 and mesoderm induction early response (MIER; MIER3)/MIER3 are within these orthologous segments. We identified MIER3 as a candidate Mcs1b gene based on 4.5-fold higher mammary gland levels of MIER3 transcripts in susceptible compared with Mcs1b-resistant females. These data suggest that the human 5q11.2 breast cancer risk allele marked by rs889312 is mammary gland autonomous, and MIER3 is a candidate breast cancer susceptibility gene. CI - (c)2012 AACR. FAU - denDekker, Aaron D AU - denDekker AD AD - Center for Genetics and Molecular Medicine, Department of Biochemistry and Molecular Biology, and James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky 40292, USA. FAU - Xu, Xin AU - Xu X FAU - Vaughn, M Derek AU - Vaughn MD FAU - Puckett, Aaron H AU - Puckett AH FAU - Gardner, Louis L AU - Gardner LL FAU - Lambring, Courtney J AU - Lambring CJ FAU - Deschenes, Lucas AU - Deschenes L FAU - Samuelson, David J AU - Samuelson DJ LA - eng GR - R01 CA137052/CA/NCI NIH HHS/United States GR - P30 ES014443/ES/NIEHS NIH HHS/United States GR - P30ES014443/ES/NIEHS NIH HHS/United States GR - R01CA137052/CA/NCI NIH HHS/United States GR - T32 ES011564/ES/NIEHS NIH HHS/United States GR - T35 ES014559/ES/NIEHS NIH HHS/United States GR - ES014443/ES/NIEHS NIH HHS/United States GR - CA137052/CA/NCI NIH HHS/United States GR - T35ES014559-06/ES/NIEHS NIH HHS/United States GR - T32ES011564/ES/NIEHS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20120919 PL - United States TA - Cancer Res JT - Cancer research JID - 2984705R RN - 0 (MIER3 protein, human) RN - 0 (Nuclear Proteins) SB - IM MH - Alleles MH - Animals MH - Animals, Congenic MH - Body Weight/genetics MH - Breast Neoplasms/*genetics MH - Cell Nucleus/genetics/metabolism MH - Chromosome Mapping MH - *Chromosomes, Human, Pair 5 MH - Female MH - Genetic Predisposition to Disease MH - Genome-Wide Association Study MH - Humans MH - Mammary Neoplasms, Experimental/*genetics MH - Nuclear Proteins/*genetics/metabolism MH - Open Reading Frames MH - Rats MH - Transcription, Genetic PMC - PMC3500408 MID - NIHMS409174 COIS- Potential conflicts of interest: None. EDAT- 2012/09/21 06:00 MHDA- 2013/03/06 06:00 PMCR- 2013/11/15 CRDT- 2012/09/21 06:00 PHST- 2012/09/21 06:00 [entrez] PHST- 2012/09/21 06:00 [pubmed] PHST- 2013/03/06 06:00 [medline] PHST- 2013/11/15 00:00 [pmc-release] AID - 0008-5472.CAN-12-0748 [pii] AID - 10.1158/0008-5472.CAN-12-0748 [doi] PST - ppublish SO - Cancer Res. 2012 Nov 15;72(22):6002-12. doi: 10.1158/0008-5472.CAN-12-0748. Epub 2012 Sep 19.